An elevated body mass (BMI) index predicts far better clinical outcomes in men with metastatic hormone refractory prostate cancer (HRPC).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Halabi, S; Ou, S; Vogelzang, NJ; Small, EJ

Published Date

  • June 20, 2006

Published In

Volume / Issue

  • 24 / 18

Start / End Page

  • 230S - 230S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Atlanta, GA

Conference Start Date

  • June 2, 2006

Conference End Date

  • June 6, 2006